Micro-X Limited (MX1.AX)
AUD 0.06
(13.73%)
AUD 0.06
(13.73%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -14.35 Million AUD | 2.44% |
| 2023 | -14.71 Million AUD | 19.77% |
| 2022 | -19.01 Million AUD | -35.79% |
| 2021 | -13.6 Million AUD | -38.87% |
| 2020 | -9.28 Million AUD | 24.76% |
| 2019 | -11.44 Million AUD | 1.32% |
| 2018 | -13.09 Million AUD | 32.14% |
| 2017 | -19.29 Million AUD | -0.23% |
| 2016 | -19.25 Million AUD | -154.22% |
| 2015 | -7.57 Million AUD | -58360.71% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -6.36 Million AUD | 0.0% |
| 2024 Q4 | -8.03 Million AUD | 0.0% |
| 2024 FY | - AUD | 10.89% |
| 2023 Q4 | -8.83 Million AUD | 0.0% |
| 2023 Q2 | -6.3 Million AUD | 0.0% |
| 2023 FY | - AUD | 19.77% |
| 2022 Q2 | -9.69 Million AUD | 0.0% |
| 2022 FY | - AUD | -35.79% |
| 2022 Q4 | -8.64 Million AUD | 0.0% |
| 2021 Q2 | -4.6 Million AUD | 0.0% |
| 2021 Q4 | -8.89 Million AUD | 0.0% |
| 2021 FY | - AUD | -38.87% |
| 2020 Q4 | -5.47 Million AUD | 0.0% |
| 2020 Q2 | -4.24 Million AUD | 0.0% |
| 2020 FY | - AUD | 24.76% |
| 2019 FY | - AUD | 1.32% |
| 2019 Q2 | -7.04 Million AUD | 0.0% |
| 2019 Q4 | -5 Million AUD | 0.0% |
| 2018 FY | - AUD | 32.14% |
| 2018 Q4 | -5.47 Million AUD | 0.0% |
| 2018 Q2 | -7.62 Million AUD | 0.0% |
| 2017 FY | - AUD | -0.23% |
| 2017 Q2 | -11.31 Million AUD | 0.0% |
| 2017 Q4 | -7.97 Million AUD | 0.0% |
| 2016 FY | - AUD | -154.22% |
| 2016 Q4 | -16.62 Million AUD | 0.0% |
| 2016 Q2 | -2.62 Million AUD | 0.0% |
| 2015 Q3 | - AUD | 100.0% |
| 2015 FY | - AUD | -58360.71% |
| 2015 Q4 | -5.16 Million AUD | 0.0% |
| 2015 Q2 | -2.4 Million AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 60.21% |
| Adherium Limited | -11.56 Million AUD | -24.096% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -94.984% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -164.608% |
| Anteris Technologies Ltd | -66.9 Million AUD | 78.55% |
| Control Bionics Limited | -5.15 Million AUD | -178.217% |
| CardieX Limited | -6.71 Million AUD | -113.816% |
| Compumedics Limited | 2.78 Million AUD | 614.557% |
| Cochlear Limited | 579.5 Million AUD | 102.476% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -310.991% |
| Cyclopharm Limited | -3.03 Million AUD | -372.866% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -586.254% |
| Nova Eye Medical Limited | -5.97 Million AUD | -140.023% |
| HeraMED Limited | -3.97 Million AUD | -261.298% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 34.382% |
| ImpediMed Limited | -22.05 Million AUD | 34.919% |
| InhaleRx Limited | -1.41 Million AUD | -915.107% |
| LBT Innovations Limited | -4.04 Million AUD | -254.433% |
| Neurotech International Limited | -8.24 Million AUD | -74.077% |
| OncoSil Medical Limited | -11.97 Million AUD | -19.83% |
| PolyNovo Limited | 5.17 Million AUD | 377.582% |
| Respiri Limited | -7.04 Million AUD | -103.563% |
| SomnoMed Limited | -2.32 Million AUD | -516.29% |
| Universal Biosensors, Inc. | -9.09 Million AUD | -57.869% |
| Uscom Limited | -1.5 Million AUD | -850.832% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -191.842% |